Intelligent Bio Solutions reports record Q1 revenue of $1.11M, up 28% YoY; gross margin expands to 46.6%

INTELLIGENT BIO SOLUTIONS INC.

2026-Q1 EPS reported -$0.35 revenue$1,111,797

Revenue $1.11M (+28% YoY, +32% sequential); cartridge sales 57.6% of total revenue.
Gross margin 46.6%, up 690 bps YoY, citing operational efficiency and product mix.
Added 33 new customer accounts; total active accounts 492 across 24+ countries.
Secured major contract with London public transport operator covering 14 sites and 4,400+ staff.
Expanded portfolio with SmarTest® Patch and global distribution deal with SMARTOX®.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.